These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 36240831

  • 1. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
    Murhekar MV, Gupta N, Hasan AZ, Kumar MS, Kumar VS, Prosperi C, Sapkal GN, Thangaraj JWV, Kaduskar O, Bhatt V, Deshpande GR, Thankappan UP, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sharma S, Sarmah NP, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Shrivastava AK, Chonker SK, Tilekar B, Tandale BV, Ahmad M, Sangal L, Winter A, Mehendale SM, Moss WJ, Hayford K.
    Lancet Glob Health; 2022 Nov; 10(11):e1655-e1664. PubMed ID: 36240831
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M, Miyano S, Mori Y, Vynnycky E, Keungsaneth P, Vongphrachanh P, Xeuatvongsa A, Sisouk T, Som-Oulay V, Khamphaphongphane B, Sengkeopaseuth B, Pathammavong C, Phounphenghak K, Kitamura T, Takeda M, Komase K.
    PLoS One; 2018 Nov; 13(3):e0194931. PubMed ID: 29596472
    [Abstract] [Full Text] [Related]

  • 5. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
    Salvi N, Itta KC, Lachyan A, Hasan AZ, Prosperi C, Kumar MS, Wesley Vivian Thangaraj J, Kaduskar O, Bhatt V, Sapkal GN, Murhekar M, Gupta N, Mehendale S, Hayford K, Moss WJ, Chauhan S, Kulkarni R.
    PLoS One; 2022 Apr 17; 17(8):e0271920. PubMed ID: 35925959
    [Abstract] [Full Text] [Related]

  • 8. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
    Mak J, Patenaude BN, Mutembo S, Pilewskie ME, Winter AK, Moss WJ, Carcelen AC.
    Am J Trop Med Hyg; 2024 Jul 03; 111(1):121-128. PubMed ID: 38772386
    [Abstract] [Full Text] [Related]

  • 9. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
    Hachiya M, Vynnycky E, Mori Y, Do HT, Huynh MK, Trinh LH, Nguyen DD, Tran NAT, Hoang TT, Hoang HHT, Vo NDT, Le TH, Ichimura Y, Miyano S, Okawa S, Thandar MM, Yokobori Y, Inoue Y, Mizoue T, Takeda M, Komada K.
    Int J Infect Dis; 2024 Jul 03; 144():107053. PubMed ID: 38641317
    [Abstract] [Full Text] [Related]

  • 10. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 May 03; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L, Germann D, Bally F, Schopfer K.
    Eur J Epidemiol; 1997 Jan 03; 13(1):61-6. PubMed ID: 9062781
    [Abstract] [Full Text] [Related]

  • 16. Measles and rubella immunity in the population of Bhutan, 2017.
    Wangchuk S, Nogareda F, Tshering N, Khandu L, Pelden S, Wannemuehler K, Wangdi S, Wangchuk U, Mulders M, Tamang T, Patel MK.
    Vaccine; 2019 Oct 08; 37(43):6463-6469. PubMed ID: 31500970
    [Abstract] [Full Text] [Related]

  • 17. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022.
    Shanmugasundaram D, Viswanathan R, Winter AK, Agarwal A, Roychowdhury B, Muliyil D, Prasad GRV, Pushpalatha K, Gowda M, Singh P, Priyasree J, Bonu R, Jha S, Kumar Jena S, Jain S, Suri V, Hebbale V, Jain A, Mary Abraham A, Mishra B, Kumar Pati B, Biswas D, Pratkeye D, Ashok M, Singh MP, Dhodapkar R, Ray R, Gadepalli R, Ratho RK, Rani S, Shukla S, Ali A S, Lakshmi Nag V, Sabarinathan R, Saravana Kumar V, Priya R P, Dwibedi B, Sapkal G, Singh H, Singh K, Tiwari L, Jain M, Mondal N, Sreenivasan P, Mahantesh S, Verma S, Awasthi S, Malik S, Santhanam S, Datta S, Kumar A, Kant Chowdhary B, Khera D, Jain M, Kumar P, Pati S, Tripathi S, Murhekar M.
    Vaccine; 2024 Oct 24; 42(24):126077. PubMed ID: 38960788
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, Deshmukh RA, Chowdhary AS.
    Viral Immunol; 2016 Apr 24; 29(3):159-63. PubMed ID: 26910764
    [Abstract] [Full Text] [Related]

  • 19. Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study.
    Motaze NV, Makhathini L, Smit SB, Adu-Gyamfi CG, Fortuin M, Wiysonge CS, Suchard SM.
    Hum Vaccin Immunother; 2020 Nov 01; 16(11):2656-2662. PubMed ID: 32298204
    [Abstract] [Full Text] [Related]

  • 20. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC, Rhoda DA, Lacoul M, Prier ML, Gautam JS, Pokhrel TN, Dixit SM, Rajbhandari RM, Bose AS.
    BMC Public Health; 2022 Feb 03; 22(1):221. PubMed ID: 35114969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.